RecruitingEarly Phase 1NCT06377839

Pain After Removal of Mandibular Third Molars With or Without Advanced Platelet-rich Fibrin

Assessment of Chronic Pain Predictors Following Surgical Removal of Mandibular Third Molars


Sponsor

Aalborg University Hospital

Enrollment

80 participants

Start Date

Jan 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Pain is the most common complication following surgical removal of an impacted mandibular third molar. Several risk factors may increase the intensity and duration of pain following removal of mandibular third molars. Acute postoperative pain can transcript into postoperative chronic pain without an explainable reason or a specific risk factor. The use of advanced platelet-rich fibrin in the extraction socket following surgical removal of mandibular third molar have diminished the intensity and duration of acute postoperative pain and facilitated improved wound healing. The objective of the present study is therefore to identified specific risk factors and predictors for developing postoperative chronic pain following surgical removal of mandibular third molars with or without advanced platelet-rich fibrin applied in the extraction socket using epigenetic modulation.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age ≥ 18 years.
  • Presence of a semi- or fully impacted mandibular third molar.
  • Indication for surgical removal of mandibular third molar.

Exclusion Criteria4

  • Patients suffering from chronic pain syndrome.
  • Patients in need of daily analgetic.
  • Pregnancy.
  • Psychiatric problems or unrealistic expectations.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAdvanced platelet-rich fibrin in the ekstraction socket

Advanced platelet-rich fibrin is a centrifuged fibrin matrix composed of concentrated growth factors, platelet cytokines, and blood cells, which possesses the ability to stimulate wound healing and tissue regeneration. Advanced platelet-rich fibrin is manufacturing from a blood sample.


Locations(1)

Department of Oral and Maxillofacial surgery, Aalborg University Hospital

Aalborg, North Denmark, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06377839


Related Trials